once monthly glp 1 agonist Maridebart cafraglutide — a GLP-1 receptor and glucose-dependent insulinotropic polypeptide receptor antagonist — is being studied as a once- obesity treatment. Research findings from the MariTide phase 2 trial are summarized PDB-101: Molecule of the Month:

We ask our patients to think of a far more sophisticated and personalized view of their healthspan

While the precise molecular intermediaries and signaling pathways remain to be clarified, ipamorelins influence on bone-associated endocrine loops (involving growth hormone and maybe local IGF-I) is plausibly central, potentially altering the balance between bone-forming and bone-remodeling processes at the tissue level

Nivelul celular al glutationului este stimulat de acidul alfa lipoic, glutamina, colostru, seleniu si vitaminele C, B6 si B2

Specialized Solvents: Dilute acetic acid or DMSO may be required for highly hydrophobic peptides or sequences with poor aqueous solubility

PubMed ID: 3169264 Pickart L & Margolina A (2018) Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of New Gene Data PMC6073405 Gorouhi F & Maibach H (2009) GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration PMC4508379 / PubMed ID: 26236730 Finkley MB et al